Greenwich LifeSciences Inc.

33.64+1.04+3.19%Vol 300.63K1Y Perf 568.40%
Apr 16th, 2021 16:00 DELAYED
BID31.90 ASK34.50
Open32.50 Previous Close32.60
Pre-Market- After-Market-
 - -  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap- 
Earnings Rating
Price Range Ratio 52W %
19.62 
Earnings Date
-

Today's Price Range

31.2534.25

52W Range

3.26158.07

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-37.24%
1 Month
14.42%
3 Months
-10.17%
6 Months
603.03%
1 Year
568.40%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
GLSI33.641.04003.19
AAPL134.16-0.3400-0.25
GOOG2 297.761.10000.05
MSFT260.741.24000.48
XOM56.66-0.3200-0.56
WFC43.841.60003.79
JNJ162.241.85001.15
FB306.18-1.6400-0.53
GE13.39-0.1600-1.18
JPM153.301.13000.74
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume300.63K
Shares Outstanding0
Trades Count4.46K
Dollar Volume6.32M
Avg. Volume630.75K
Avg. Weekly Volume791.11K
Avg. Monthly Volume1.08M
Avg. Quarterly Volume680.66K

Greenwich LifeSciences Inc. (NYSE: GLSI) stock closed at 33.64 per share at the end of the most recent trading day (a 3.19% change compared to the prior day closing price) with a volume of 301.15K shares and market capitalization of 0.0000. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 3 people. Greenwich LifeSciences Inc. CEO is Snehal Patel.

The one-year performance of Greenwich LifeSciences Inc. stock is 568.4%, while year-to-date (YTD) performance is -7.76%. GLSI stock has a five-year performance of %. Its 52-week range is between 3.26 and 158.07, which gives GLSI stock a 52-week price range ratio of 19.62%

Greenwich LifeSciences Inc. currently has a PE ratio of -252.50, a price-to-book (PB) ratio of 23.48, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -12.98%, a ROC of -22.51% and a ROE of -14.18%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Greenwich LifeSciences Inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Greenwich LifeSciences Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Greenwich LifeSciences Inc. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Greenwich LifeSciences Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Greenwich LifeSciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Greenwich LifeSciences Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 25.06, ATR14 : 6.19, CCI20 : -45.13, Chaikin Money Flow : -0.38, MACD : -0.38, Money Flow Index : 79.48, ROC : 2.25, RSI : 32.52, STOCH (14,3) : 9.83, STOCH RSI : 0.06, UO : 27.94, Williams %R : -90.17), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Greenwich LifeSciences Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

Greenwich LifeSciences Inc.

Greenwich LifeSciences Inc is a clinical stage bio-pharmaceutical company focused on the development of an immunotherapy to prevent breast cancer recurrences in patients.

CEO: Snehal Patel

Telephone: +1 832 819-3232

Address: 3992 Bluebonnet Drive, Stafford 77477, TX, US

Number of employees: 3

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

75%25%

Bearish Bullish

100%0%

Bearish Bullish

67%33%

News

Stocktwits